Contact Us

27 April 2023 Ian Glover

Contact LetsGoPharm

We at LetsGoPharm are dedicated to providing our readers with reliable and accessible information regarding pharmaceuticals, healthcare, and wellness. If you have any questions, suggestions, or feedback, please do not hesitate to reach out to us.

Our Mailing Address

Mailbox Birmingham,
Birmingham B1 1LT,
United Kingdom

Email Us

For any inquiries, you can email our team at: [email protected]

Contact Form

If you prefer, you can use the contact form below to send us a message directly:

Ian Glover
Ian Glover

My name is Maxwell Harrington and I am an expert in pharmaceuticals. I have dedicated my life to researching and understanding medications and their impact on various diseases. I am passionate about sharing my knowledge with others, which is why I enjoy writing about medications, diseases, and supplements to help educate and inform the public. My work has been published in various medical journals and blogs, and I'm always looking for new opportunities to share my expertise. In addition to writing, I also enjoy speaking at conferences and events to help further the understanding of pharmaceuticals in the medical field.

More Articles

How to Buy Cheap Generic Neurontin Online Safely
Ian Glover

How to Buy Cheap Generic Neurontin Online Safely

Learn how to safely buy cheap generic Neurontin (gabapentin) online, spot legit pharmacies, compare prices, and avoid scams with a step‑by‑step guide.

Symbicort vs Alternatives: What Works Best for Asthma and COPD?
Ian Glover

Symbicort vs Alternatives: What Works Best for Asthma and COPD?

Symbicort (budesonide/formoterol) helps manage asthma and COPD, but it's not the only option. Learn about cheaper generics, alternative inhalers like Fostair and Advair, and when to consider triple therapy.

Rheumatoid Arthritis Medications: DMARD and Biologic Interactions
Ian Glover

Rheumatoid Arthritis Medications: DMARD and Biologic Interactions

Rheumatoid arthritis treatment relies on DMARDs and biologics to stop joint damage. Methotrexate remains first-line, but biologics and JAK inhibitors offer stronger control for severe cases-with trade-offs in cost, side effects, and long-term safety.